Section Menu

Pediatric Medicine News, Research & Innovation


At the Leading Edge of Pediatric Cardiac Catheterization

diciembre 18, 2023 – Widely recognized as a world leader in pediatric interventional cardiac catheterization, the team at the Nicklaus Children’s Hospital's Heart Institute not only utilizes the most advanced devices, procedures, and treatments, they also ensure families remain the focus by actively communicating. This includes calling a patient's parents "every hour while the procedure takes place.” 

Our Team's Comprehensive Approach to Pediatric Thyroid and Endocrine Surgery

noviembre 30, 2023 – While remaining relatively rare, Thyroid cancer is the most common form pediatric endocrine cancer, encompassing 6% of all pediatric cancers. Treatment doesn’t just start and end with surgery, Nicklaus Children's specialists and researchers are also examining the molecular makeup of thyroid carcinomas to better inform surgical techniques and treatment protocols.

Meeting the Needs of All Children With Endocrine Disorders

noviembre 30, 2023 – Nicklaus Children's Hospital offers comprehensive, multidisciplinary care for a complete spectrum of endocrine disorders for children from infancy through adolescence. They offer personalized care for children with diabetes, including medication, guidance for eating, learning, exercising, and playing. The team participates in innovative clinical trials and national research, specifically focusing on new approaches to care for Type 1 diabetes. They also ensure that families have all the tools and education necessary to manage diabetes at home. 

The Full Spectrum of Pediatric Sports Medicine Care

noviembre 29, 2023 – Young athletes can succeed only if they can perform at their best. To best meet the current and future needs of young athletes, the Nicklaus Children’s Hospital Orthopedic, Sports Medicine and Spine Institute continues pushing forward as a leader in the sports medicine arena. 

Setting the Gold Standard: Advancing Care for Sarcoma and Solid Tumors

noviembre 29, 2023 – Bone and joint cancers account for a fraction of cancer cases in the U.S., and their rarity and a paucity of treatment options underscore the need for experienced, multidisciplinary care and novel solutions. Nicklaus Children's Hospital's Sarcoma and Solid Tumor Program delivers both options for children with these malignancies.

A New Era of Care for Duchenne Muscular Dystrophy

noviembre 29, 2023 – In 2023, the Food and Drug Administration (FDA) approved the first gene therapy for Duchenne muscular dystrophy (DMD). This much-needed treatment may slow or stop the progression of this debilitating and deadly disorder. Nicklaus Children’s Hospital is at the forefront of this advancement in care as one of the first hospitals in the U.S. and one of only three in Florida to offer gene therapy for DMD.